Header

Glyxambi® Overview

giant_hi

Giant Hi-5 Triumphant Years

Watch now
carousel 1

Personalize diabetes management with Giant power FDC for your T2DM Patients.

Read more
gentle-giant

Gentle Giant theme video

Watch now
carousel 3

Guidelines recommend initiation of combination therapy1-3

Read more
carousel 4

Patient Profile

Making giant impact in the T2DM patients lives with powerful A1c reduction and a secured Cardio-Renal-Metabolic legacy

Read more
carousel 5

Giant-power FDC

Meet a one-of-a-kind FDC with convenient dosing

Watch now
carousel 6

Expert Opinion

Explore our recent newsletters and stay updated with the latest guidelines

Read more
See all results
Glucometer icon.

Learn more about powerful HbA1c reduction.                                                                     

See all results
See all results
Magnifying glass on paper

Learn more about CV outcomes with Empagliflozin and Linagliptin                                                                                

See all results

  • CV: Cardiovascular disease.

  • FDC: Fixed dose combination.

  • HbA1c: Glycated haemoglobin.

  • SGLT2i: Sodium-glucose co-transporter 2 inhibitor.

  • DPP4i: Dipeptidyl peptidase 4 inhibitor.

Disclaimer:

  • Glyxambi is not indicated for BP or weight reduction.